Choosing the Right Weight Loss Method The choice between Semaglutide and traditional dieting methods depends on your unique circumstances, preferences, and goals
(Phase 2 trial) Eli Lilly TRIUMPH-1 Phase 3 topline results, including 80-week and 104-week extension data (May 21, 2026)
Provider-guided monitoring is considered in the context of your overall health plan, clinical eligibility, and long-term goals
If you have been unable to lose weight through lifestyle modifications such as diet and exercise and fit the medical qualifications, you may be a candidate for semaglutide
The pilot program has been a bit of a roller coaster for patients, says Bisher Mustafa, a weight-management specialist at Marshall Health, one of the centers in the PEIA pilot program